News | November 12, 2021
Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
The company will provide the technical and financial resources to support the study
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
The consideration for the acquisition is US $ 2.25 million
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
